In December, President Donald Trump in an executive order told his attorney general to expediate a rulemaking process related ...

It's an unuaual company, in that it doesn't sell a single ounce of weed.

Canopy Growth Corporation CGC is back in focus as marijuana reclassification efforts revive investor interest in cannabis ...

These companies are major players in the U.S. marijuana market, and they all generated more than $1 billion in revenue last year.

For anyone who has observed Canopy Growth (NASDAQ: CGC) during the past few years, it won't be shocking to learn that the ...

Trulieve Cannabis and Green Thumb Industries are already two of the top cannabis retailers in the U.S. The Department of Justice reclassification makes them even stronger.

Cannabis stocks and funds that hold them surged after the Trump administration moved it from the government most restrictive drug category to one that can be obtainable with a prescription.

Marijuana industry growth is projected at 34% annually through 2030, attracting investors. DEA's reclassification of marijuana could significantly broaden market and investment scopes. Investor guide ...

The Department of Justice said it will immediately move FDA-approved marijuana from Schedule I to Schedule III under the Controlled Substances Act.